Sort
35,931 grants matching “parkinsons”
Molecular, anatomic, and functional characterization of midbrain dopamine neuron subtypes
$743,574Daniel A Dombeck · Northwestern University · R01 · FY2017 · MH
Role of Neurotrophins in the Development of the Mammalian Nervous System
$743,429Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Assessing skin biomarkers for preclinical diagnosis of PD and non-PD Parkinsonism
$743,089Wen-Quan Zou · Case Western Reserve University · U01 · FY2020 · NS
Remote Electromagnetic Control of Neural Activity for Treatment of Parkinson's Disease
$742,909Jeffrey M Friedman · Rockefeller University · R01 · FY2016 · NS
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes, Their Progression, and Pathological Relevance
$742,806Richard B Mailman · Pennsylvania State Univ Hershey Med Ctr · U01 · FY2023 · NS
Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease
$742,741Paul T Kotzbauer · Washington University · R01 · FY2022 · NS
Anxiety in Parkinsonâs disease: using fMRI to evaluate amygdala networks in the on and off dopamine state
$742,576Gregory Michael Pontone · University Of Florida · R01 · FY2025 · MH
Bioactive lipids as effectors and indicators of the deleterious effects of environmental exposure on chronic diseases
$742,563Bruce D Hammock · University Of California At Davis · R35 · FY2019 · ES
Vitamin K and D and Cognitive Impairment in Older Adults
$742,446Sarah Booth · Tufts University Boston · R01 · FY2024 · AG
Establishment of a UMDNJ NeuroProteomics Core Facility
$742,427Univ Of Med/Dent Of Nj-Nj Medical School · P30 · FY2005 · NS
Assay of chemicals for Parkinson's toxicity in human iPSC-derived neurons
$742,257Patrick M McDonough · Vala Sciences, Inc. · R44 · FY2019 · ES
Development of marmoset models of neurodegenerative disease using embryonic stem cell-based gene-editing approaches
$742,128Kuo-Fen Lee · Salk Institute For Biological Studies · R24 · FY2017 · OD
Investigating neuroanatomical underpinnings of apathy in ADRD through neuroimaging and electrical manipulation
$742,127Nora Vanegas-Arroyave · Baylor College Of Medicine · R01 · FY2024 · MH
Modeling functional genomics of susceptibility to the persistent effects of environmental toxins in an elderly rural Indiana neurodegenerative cohort
$742,044Aaron B Bowman · Purdue University · R01 · FY2024 · AG
Using Transport to Map the Brain
$741,980Elaine L Bearer · University Of New Mexico · R01 · FY2010 · NS
Anti-inflammatory signals and neurodegeneration
$741,976Bruno Conti · San Diego Biomedical Research Institute · R01 · FY2024 · NS
Epidemiologic Study of Brain Vitamin E, Diet & Age-Related Neurologic Diseases
$741,860Martha C. Morris · Rush University Medical Center · R01 · FY2009 · AG
Citalopram as a posterior cortical protective therapy in Parkinson disease
$741,668Vikas Kotagal · University Of Michigan At Ann Arbor · R01 · FY2021 · AG
Development of EP2 receptor antagonists for suppression of Alzheimer's neuropathology
$741,585Thota Ganesh · Emory University · U01 · FY2017 · AG
Behavioral role of hypocretin (orexin)
$741,530Jerome M Siegel · University Of California Los Angeles · R01 · FY2012 · MH
Citalopram as a posterior cortical protective therapy in Parkinson disease
$740,669Vikas Kotagal · University Of Michigan At Ann Arbor · R01 · FY2022 · AG
The neural bases of placebo effects and their relation to regulatory processes
$740,565Tor Dessart Wager · Dartmouth College · R01 · FY2021 · MH
Health Effects Of Exposures In Agriculture
$740,470Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
Dorsal Column Stimulation as a New Therapy for Motor Disorders
$740,239Miguel A. L. Nicolelis · Duke University · R01 · FY2013 · NS
Investigating neuroanatomical underpinnings of apathy in ADRD through neuroimaging and electrical manipulation
$740,147Nora Vanegas-Arroyave · Baylor College Of Medicine · R01 · FY2021 · MH